Physician profile
Leonid Reshko
NPI 1770016065
$2,507.84
in general payments reported to CMS, 2019-2025
21 companies · $25.40 in 2025
The $25.40 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $44.18 · 2021: $424 · 2022: $299 · 2023: $178 · 2024: $1,303 · 2025: $25.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $951 · Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $950.97 |
| Food and Beverage | $555.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $950.97 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $285.45 | 2021-2022 | |
| Novocure INC. | $235.52 | 2022-2024 | Optune |
| Boston Scientific Corporation | $167.22 | 2021-2024 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $159.81 | 2024 | |
| Celgene Corporation | $129.43 | 2019 | |
| Tactile Systems Technology INC | $118.18 | 2023 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $94.28 | 2019-2022 | |
| Reflexion Medical, INC. | $73.54 | 2024 | Reflexion Medical Radiotherapy System |
| Tesaro, INC. | $53.06 | 2019 | |
| Incyte Corporation | $48.21 | 2019-2021 | |
| Zap Surgical Systems, INC. | $37.63 | 2024 | Zap-X Radiosurgery System, Zap-X Mv Imager, Zap-X Treatment Planning Software |
| Arbor Pharmaceuticals, INC. | $26.41 | 2021 | |
| Siemens Medical Solutions USA, INC. | $25.40 | 2025 | Truebeam |
| E.R. Squibb & Sons, L.L.C. | $17.88 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $17.00 | 2023 | |
| Eisai INC. | $15.13 | 2021 | |
| Lilly USA, LLC | $14.25 | 2019 | |
| Amgen INC. | $13.99 | 2021 | |
| Genzyme Corporation | $12.94 | 2021 | |
| Daiichi Sankyo INC. | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonid Reshko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.